Tomohiro Kadota, Seiichiro Abe, Noriya Uedo, Hisashi Doyama, Yasuaki Furue, Manabu Muto, Satoru Nonaka, Hiroyuki Takamaru, Tatsuro Murano, Keiichiro Nakajo, Yasuhiro Tani, Yuki Okubo, Azusa Kawaaski, Naohiro Yoshida, Akinori Watanabe, Chikatoshi Katada, Masashi Tamaoki, Akira Yokoyama, Hideki Furuya, Takashi Ikeno, Masashi Wakabayashi, Tomonori Yano
OBJECTIVES: The early detection of gastric neoplasms (GNs) leads to favorable treatment outcomes. The latest endoscopic system, EVIS X1, includes third-generation narrowband imaging (3G-NBI), texture and color enhancement imaging (TXI), and high-definition white-light imaging (WLI). Therefore, this randomized phase II trial aimed to identify the most promising imaging modality for GN detection using 3G-NBI and TXI. METHODS: Patients with scheduled surveillance endoscopy after a history of esophageal cancer or GN or preoperative endoscopy for known esophageal cancer or GN were randomly assigned to the 3G-NBI, TXI, or WLI groups...
May 16, 2024: American Journal of Gastroenterology